Abattis Bioceuticals (ATTBF) Short Interest Ratio & Short Volume Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume6,150 shsAverage Volume11,650 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Short InterestStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Abattis Bioceuticals Short Interest DataCurrent Short Volume10,600 sharesPrevious Short Volume0 sharesChange Vs. Previous Month+∞Dollar Volume Sold Short$0.00Short Interest Ratio / Days to Cover0.0Last Record DateNovember 15, 2021Today's Trading Volume6,150 sharesAverage Trading Volume11,650 sharesToday's Volume Vs. Average53% Short Selling Abattis Bioceuticals ? Sign up to receive the latest short interest report for Abattis Bioceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatATTBF Short Interest Over TimeATTBF Days to Cover Over TimeATTBF Percentage of Float Shorted Over Time Abattis Bioceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/202110,600 shares $0.00 No ChangeN/A0 $0.00 8/13/202121,900 shares $302.22 No ChangeN/A0 $0.01 5/28/2021100 shares $1.38 -95.7%N/A0 $0.01 5/14/20212,300 shares $33.12 +475.0%N/A0 $0.01 4/30/2021400 shares $6.52 -97.3%N/A0 $0.02 4/15/202114,900 shares $286.08 +14,800.0%N/A0 $0.02 Get the Latest News and Ratings for ATTBF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Abattis Bioceuticals and its competitors with MarketBeat's FREE daily newsletter. 3/31/2021100 shares $2.50 No ChangeN/A0 $0.03 3/15/2021100 shares $2.25 -90.0%N/A0 $0.02 2/26/20211,000 shares $23.00 +900.0%N/A0 $0.02 2/12/2021100 shares $3.40 No ChangeN/A0 $0.03 1/29/2021100 shares $1.57 -98.9%N/A0 $0.02 1/15/202117,700 shares $230.10 +90.3%N/A0 $0.01 12/31/20209,300 shares $124.43 -47.5%N/A0 $0.01 12/15/202017,700 shares $261.96 +90.3%N/A0 $0.01 11/30/20209,300 shares $63.71 No ChangeN/A0 $0.01 8/14/20207,700 shares $54.67 -90.7%N/A0 $0.01 7/31/202083,100 shares $648.18 +1,788.6%N/A0.2 $0.01 7/15/20204,400 shares $35.20 -59.6%N/A0 $0.01 6/30/202010,900 shares $94.83 -65.5%N/A0 $0.01 6/15/202031,600 shares $312.84 +54.2%N/A0 $0.01 5/29/202020,500 shares $176.30 +365.9%N/A0 $0.01 5/15/20204,400 shares $31.24 No ChangeN/A0 $0.01 4/15/202065,700 shares $394.20 No ChangeN/A0.1 $0.01 2/28/202011,400 shares $95.76 +159.1%N/A0 $0.01 2/14/20204,400 shares $47.08 -84.6%N/A0 $0.01 1/31/202028,600 shares $380.38 -87.5%N/A0 $0.01 1/15/2020228,000 shares $3,420.00 No ChangeN/A0.1 $0.02 ATTBF Short Interest - Frequently Asked Questions What is Abattis Bioceuticals' current short interest? Short interest is the volume of Abattis Bioceuticals shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 10,600 shares of ATTBF short. Learn More on Abattis Bioceuticals' current short interest. Is Abattis Bioceuticals' short interest increasing or decreasing? Abattis Bioceuticals saw a increase in short interest in November. As of November 15th, there was short interest totaling 10,600 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($11.06 billion), S&P Global Inc. ($8.74 billion), Charter Communications, Inc. ($5.66 billion), Canadian Pacific Kansas City Limited ($5.43 billion), Wayfair Inc. ($4.23 billion), Palo Alto Networks, Inc. ($3.46 billion), DoorDash, Inc. ($3.41 billion), Teladoc Health, Inc. ($2.84 billion), Etsy, Inc. ($2.76 billion), and Zscaler, Inc. ($2.62 billion). View all of the most shorted stocks. What does it mean to sell short Abattis Bioceuticals stock? Short selling ATTBF is an investing strategy that aims to generate trading profit from Abattis Bioceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Abattis Bioceuticals? A short squeeze for Abattis Bioceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATTBF, which in turn drives the price of the stock up even further. How often is Abattis Bioceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATTBF, twice per month. The most recent reporting period available is November, 15 2021. More Short Interest Resources from MarketBeat Related Companies: 1933 Industries Short Interest Data 4Front Ventures Short Interest Data AB Science Short Interest Data Acreage Short Interest Data Acreage Short Interest Data Aleafia Health Short Interest Data Almirall Short Interest Data Alvotech Short Interest Data Amazonas Florestal Short Interest Data American Green Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ATTBF) was last updated on 12/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abattis Bioceuticals Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.